Tepilamide fumarate

CAS No. 1208229-58-6

Tepilamide fumarate( XP 23829 )

Catalog No. M10774 CAS No. 1208229-58-6

A small-molecule, fumaric acid ester (FAE) compound that is a prodrug of methyl hydrogen fumarate (also known as monomethyl fumarate).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 77 In Stock
5MG 67 In Stock
10MG 98 In Stock
25MG 198 In Stock
50MG 277 In Stock
100MG 384 In Stock
200MG 528 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Tepilamide fumarate
  • Note
    Research use only, not for human use.
  • Brief Description
    A small-molecule, fumaric acid ester (FAE) compound that is a prodrug of methyl hydrogen fumarate (also known as monomethyl fumarate).
  • Description
    A small-molecule, fumaric acid ester (FAE) compound that is a prodrug of methyl hydrogen fumarate (also known as monomethyl fumarate), for the treatment of relapsing-remitting multiple sclerosis and plaque psoriasis.Psoriasis Phase 2 Clinical.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    XP 23829
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Other Targets
  • Research Area
    Inflammation/Immunology
  • Indication
    Psoriasis

Chemical Information

  • CAS Number
    1208229-58-6
  • Formula Weight
    243.259
  • Molecular Formula
    C11H17NO5
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : ≥ 125 mg/mL 513.85 mM
  • SMILES
    O=C(OCC(N(CC)CC)=O)/C=C/C(OC)=O
  • Chemical Name
    (N,N-Diethylcarbamoyl)methyl methyl (2E)-but-2-ene-1,4-dioate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Type A Allatostatin ...

    Type A Allatostatin I b

  • NCGC00135472

    NCGC00135472 (DRV1 (GPR32) agonist C2A) is a human Resolvin DI receptor DRV1 agonist with pro-catabolic properties that activates the human soluble protein D1 receptor DRV1/GPR32 receptor in beta-blocker and cAMP assays with EC50s of 0.37 uM and 0.05 uM, respectively.

  • sEH inhibitor-7

    sEH inhibitor-7 is a soluble epoxide hydrolase (sEH) inhibitor that inhibits sEH in human and mouse with IC 50 s of 6.2 μM and 0.15 μM, respectively. sEH inhibitor-7 is associated with anti-inflammatory active molecules.